What is Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate?
Category: Prescription Drugs
Most popular types: Atripla
The antiretroviral drugs efavirenz, emtricitabine, and tenofovir disoproxil fumarate are combined to be taken as one tablet once a day. It may be prescribed for use alone as a complete treatment option or in combination with other antiretroviral medications.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Human immunodeficiency virus (HIV) | 655 | 278 | |
| Support immune health | 21 | 17 | |
| General health | 6 | 4 | |
| Low CD4 count | 3 | 3 | |
| Acquired immune deficiency syndrome (AIDS) | 2 | 1 | |
| None | 2 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 30 | |
| Moderate | 57 | |
| Mild | 129 | |
| None | 66 |
Commonly reported side effects and conditions associated with Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate
| Side effect | Patients | Percentage |
|---|---|---|
| Vivid dreams | 72 | |
| Dizziness | 51 | |
| Tiredness | 28 | |
| Inconsistent sleep pattern | 25 | |
| Balance problems | 14 | |
| Flatulence | 11 |
Why patients stopped taking Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Side effects too severe | 50 | |
| Doctor's advice | 40 | |
| Other | 12 | |
| Personal research | 6 | |
| Did not seem to work | 4 | |
| Change in health plan coverage | 2 | |
| Expense | 2 |
Duration
Stopped taking Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 17 | |
| 1 - 6 months | 12 | |
| 6 months - 1 year | 14 | |
| 1 - 2 years | 15 | |
| 2 - 5 years | 21 | |
| 5 - 10 years | 15 |
What people switch to and from
Patients started taking Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Emtricitabine-Tenofovir disoproxil fumarate (Truvada) | 3 | |
| Fosamprenavir (FPV) (Lexiva) | 1 | |
| Nevirapine (NVP) (Viramune) | 1 | |
| Raltegravir (RAL) (Isentress) | 1 | |
| Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine (Complera) | 1 |
Patients stopped taking Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide (Genvoya) | 5 | |
| Emtricitabine-Tenofovir disoproxil fumarate (Truvada) | 5 | |
| Dolutegravir (DTG) (Tivicay) | 4 | |
| Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine (Complera) | 4 | |
| Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF) (Biktarvy) | 2 |
Last updated: